Company intelligence / Profile preview

Virotek

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

Virotek is an Australian healthcare company specializing in the development and distribution of rapid diagnostic solutions for infectious diseases. The company is best known for its comprehensive range of Rapid Antigen Tests (RATs), which provide quick and accurate results for viruses such as SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV). Virotek serves a diverse client base, including healthcare institutions, government agencies, and corporate sectors, offering both professional-use and self-test diagnostic kits. Their products are designed to facilitate rapid screening and clinical decision-making in point-of-care settings.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic TestRapid Antigen Test
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Virotek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virotek.

Explore the full profile